Cromos Pharma successfully completes enrollment for a Phase II COVID-19 vaccine clinical trial Cromos Pharma today (Thursday, 16 September, 2021) announced that it has successfully completed recruitment for a Phase II COVID-19 vaccine clinical trial. Cromos Pharma is pleased to achieve this important milestone for this vaccine study which will contribute to the ongoing fight against the COVID-19 pandemic. This enrollment is the latest success for Cromos Pharma, a US-based
Cromos Pharma’s Patient Portal now available in multiple languages As part of our ongoing commitment to ensuring patients are well informed about their role in the clinical trials process, Cromos Pharma has translated its patient information into multiple languages. At our patients portal, you will now find this information in English, Polish, Georgian, Czech, and Hungarian. You can access our patient portal here. Being a participant in
Getting ready for full implementation of the EU Clinical Trial Regulation The countdown is on for the European Union (EU) Clinical Trial Regulation (Regulation (EU) No 536/2014) (CTR) with a go-live date of 31 January 2022. The implementation of the CTR will bring about significant changes to the way clinical trials are conducted in the EU. In this article Cromos Pharma considers some of the requirements for sponsors. The
